Getinge (OTCMKTS: GNGBY) is one of 65 public companies in the “Electromedical equipment” industry, but how does it compare to its peers? We will compare Getinge to similar companies based on the strength of its institutional ownership, profitability, valuation, dividends, analyst recommendations, earnings and risk.
Earnings and Valuation
This table compares Getinge and its peers top-line revenue, earnings per share and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Getinge||$3.25 billion||$353.05 million||23.85|
|Getinge Competitors||$999.91 million||$94.29 million||136.92|
This table compares Getinge and its peers’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Getinge pays an annual dividend of $0.26 per share and has a dividend yield of 0.7%. Getinge pays out 16.6% of its earnings in the form of a dividend. As a group, “Electromedical equipment” companies pay a dividend yield of 0.6% and pay out 28.3% of their earnings in the form of a dividend. Getinge is clearly a better dividend stock than its peers, given its higher yield and lower payout ratio.
This is a summary of current ratings for Getinge and its peers, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
As a group, “Electromedical equipment” companies have a potential upside of 16.58%. Given Getinge’s peers higher possible upside, analysts plainly believe Getinge has less favorable growth aspects than its peers.
Institutional and Insider Ownership
0.0% of Getinge shares are held by institutional investors. Comparatively, 47.7% of shares of all “Electromedical equipment” companies are held by institutional investors. 12.9% of shares of all “Electromedical equipment” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Volatility & Risk
Getinge has a beta of 0.88, meaning that its stock price is 12% less volatile than the S&P 500. Comparatively, Getinge’s peers have a beta of 20.19, meaning that their average stock price is 1,919% more volatile than the S&P 500.
Getinge beats its peers on 9 of the 15 factors compared.
Getinge AB provides products and solutions for operating rooms, intensive-care units, sterilization departments, and life science companies and institutions. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers sterile transfer systems, closure processing systems, washers, isolators, sterilizers, and logistic automation solutions; practice-oriented monitoring systems and disposables, vascular and cardiothoracic surgery solutions, anesthesia machines, beating heart surgery solutions, ceiling supply units, connected solutions, and indicators, as well as washer-disinfectors, consumables, and IT-solutions. The company also provides endovascular products; chest drain products; endoscope reprocessing; endoscopic vessel harvesting systems; ventilators; extracorporeal life support or extracorporeal membrane oxygenation products; intra-aortic balloon counter pulsation therapies; operating lights; and modular room systems. In addition, it offers operating tables and accessories; operating room (OR) furniture; OR integration systems; OR management solutions; loading and distribution trolleys; patient flow management and transport solutions; sealing equipment; sterile supply management and traceability solutions; surgical perfusion components; surgical assist systems; and trays and baskets, as well as inspection and packaging and after sales consulting services. Further, the company provides professional financial advisory services to hospitals and medical facilities; and education and training services. It offers its products through a network of proprietary sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Getinge AB was founded in 1904 and is headquartered in Gothenburg, Sweden.
Receive News & Ratings for Getinge Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Getinge and related companies with MarketBeat.com's FREE daily email newsletter.